City

Beijing (1)

Wuhan (1)

Condition

Diabetic Peripheral Neuropathy Type 2 (2)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

early phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Fengmei Lian (1)

Wuhan Central Hospital (1)

Intervention

huc-mscs (1)

lipoic acid (1)

mudan granule (1)

placebo (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (2)

diabetic peripheral neuropathy type 2

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Diabetic Peripheral Neuropathy Type 2 Trial in Wuhan (HUC-MSCs, Lipoic Acid)

Recruiting

Diabetic Peripheral Neuropathy Type 2

HUC-MSCs
Lipoic Acid

Wuhan, Hubei, China

The Central Hospital of Wuhan

Aug 16, 2022

Diabetic Peripheral Neuropathy Type 2 Trial in Beijing (Mudan granule, Placebo)

Not yet recruiting

Diabetic Peripheral Neuropathy Type 2

Mudan granule
Placebo

Beijing, China

Guang'anmen Hospital of China Academy of Chinese Medical Science

Jan 13, 2021